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1078–5Objective. Myocardial injury, detected by rises in cardiac troponin I (TnI), is common and associated with decreased
survival following open AAA surgery. We examined the relationship between perioperative myocardial injury and post-
operative outcome.
Design. Observational Cohort Study.
Methods. Forty-three consecutive patients who underwent elective open AAA repair were screened for perioperative
myocardial injury or infarction using serial TnI measurements (taken on days 1, 3, and 7), ECG and clinical assessment.
The primary outcome was survival free of cardiac failure, or myocardial infarction (MI) at follow-up.
Results. Twenty (47%) of the 43 patients had a TnI elevation. Of these, 11 (26%) patients met the criteria for MI. At
a mean (SD) follow-up of 1.5 0.8 years, 12 (28%) subjects had experienced at least one endpoint event. Survival
free of cardiac failure or MI was 55% in patients who had TnI rises compared to 87% in those without (P¼ 0.02). Logistic
regression revealed that TnI elevation was an independent predictor of outcome with an odds ratio of 5.4 (95% CI 1.2e2.4,
P¼ 0.03).
Conclusion. Perioperative myocardial injury after elective open AAA repair predicts outcome after surgery. Routine TnI
measurement should be considered in all patients, especially in those with high cardiovascular risk.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Keywords: Abdominal aortic aneurysm; Myocardial injury; Outcome.Patients undergoing major vascular surgery are at sig-
nificant risk of developing postoperative myocardial
complications, particularly myocardial infarction.1,2
Stress, hemodynamic changes, and oxygen supply
and demand mismatch frequently lead to cardiac
ischemia in these patients.3 Identifying perioperative
myocardial infraction is often difficult as chest pain
is infrequent, ECG changes are often subtle and tran-
sient3 and CK-MB may be falsely elevated as a result
of the operative procedure.4 Cardiac troponins are
highly sensitive and specific biomarkers of myocar-
dial injury which have improved the ability to diag-
nose perioperative myocardial infarction.3e6
Subclinical myocardial injury after vascular surgery,
detected by a rise in serum cardiac troponin, is com-
mon and associated with decreased survival.5,7e11
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884/000413+ 07 $34.00/0  2007 European Society for Vascularaised in nearly half of all patients undergoing emer-
gency AAA repair for rupture,12,13 and that these rises
were also associated with decreased survival.13 In
keeping with these findings, myocardial ischemia
seen as significant ST segment depression on ECG
has been shown in up to 40% of patients having elec-
tive AAA repair.14 Furthermore myocardial injury, de-
tected by rises in TnI, have been described in 25e47%
of elective AAA procedures.12,15,16 Recent reports sug-
gest that myocardial injury may be less frequent after
endovascular repair.15,16 Thus, it is important to under-
stand the prognostic implications of myocardial injury
after elective open AAA repair. We examined the rela-
tionship between perioperative myocardial injury, de-
tected by serum rises in TnI, and postoperative
outcome at a mean of 1.5 years after operation.Methods
This study represents a sub-group analysis of a ran-
domized controlled trial approved by the Cambridger Surgery. Published by Elsevier Ltd. All rights reserved.
414 Z. A. Ali et al.Research Ethics Committee.17 Each patient gave
informed, written consent. Suitable patients were in-
vited to participate in the trial at the time of scheduling
for AAA repair.Patients
Forty-three control patients from a consecutive series
of 86 enrolled in a randomized controlled trial17
who underwent elective AAA surgery were included
in this observational cohort study. On informed con-
sent to the study, baseline TnI levels were recorded.
Subsequent blood specimens were analyzed on the
morning of postoperative days 1, 3 and 7. Potential
participants were excluded from analysis if they
were more than 90 years of age; required concomitant
procedures other than AAA repair; or had experi-
enced an acute coronary syndrome or myocardial
infraction within 3 months. Demographic and clinical
variables were recorded and all patients risk stratified
according to the prospectively validated physiological
operative severity score for the enumeration of mor-
tality and morbidity (POSSUM) risk stratification
scoring system.18Treatment and procedures
Patients with cardiac symptoms were assessed by
a cardiologist and referred for non-invasive stress
testing as clinically mandated. Patients with unfavor-
able results or changes in symptoms were referred for
coronary angiography. Subsequently revascularized
patients were included in the analysis. Beta blockers
were prescribed in the absence of contraindications
preoperatively with dose titrated towards heart rate
of 60.
Patients underwent elective open AAA repair us-
ing a standardized operating technique by one of
three consultant vascular surgeons. Patients were
induced with intravenous propofol, atracurium, and
remifentanyl followed by maintenance with inhaled
desflurane. All patents received systemic hepariniza-
tion and perioperative beta-blockers titrated to a target
heart rate of 60.
Post-operatively all patients received patient-con-
trolled intravenous morphine and/or bupivicaine
and fentanyl epidural analgesia. Patients with evi-
dence of myocardial infarction in-hospital were subse-
quently managed by conventional medical treatment
including antiplatelet agents, beta-blockers, angioten-
sin converting enzyme inhibitors (or angiotensin
receptor blockers) and cholesterol lowering drugs in
the absence of any contra-indications.Eur J Vasc Endovasc Surg Vol 35, April 2008Outcomes
The primary outcome was the combined endpoint of
death, myocardial infarction or congestive cardiac
failure. Follow-up was performed by review of case
notes, death certificates, autopsy reports and struc-
tured telephone interview of all patients at the com-
pletion of study enrollment.
In hospital, myocardial injury was defined as peak
serum level> 0.54 ng/mL in keeping with published
reports correlating this level with cardiac morbidity
and mortality,7 and myocardial infarction according
to the revised ACC/AHA guidelines (TnI eleva-
tion> 1.5 ng/mL with at least one of the following:
typical ischemic symptoms, ECG changes indicative
of ischemia, or new pathological Q-waves).19 The
TnI cutoff for this definition was established in keep-
ing with published reports correlating this level with
clinical myocardial infarction.11 TnI was measured
using an automated immunoflourescence detector
(Dade Behring, Milton Keynes, UK). All patients
were monitored for ischemia for 48 hours after sur-
gery using Holter electrocardiograms (Lifecard CF,
Del Mar Reynolds, Hertford, UK) and screened using
computerized ST-segment analysis (Pathfinder, Del
Mar Reynolds, Hertford, UK).3 ST-deviations,
0.2 mV in one lead or 0.1 mV in two contiguous
leads lasting more than 10 mins, were reviewed by
a consultant cardiologist (DPD). Each patient’s num-
ber of events and longest and cumulative ischemia
duration was recorded. In addition daily 12 lead
ECGs were performed each morning perioperatively.
Cardiac failure was defined as dyspnea either at rest
or with minimal activity, paroxysmal nocturnal dysp-
nea, and edema, either pulmonary or peripheral. In
hospital following daily examination, patients with
clinical evidence of fluid overload or new pulmonary
congestion on chest radiograph were classified as car-
diac failure. In the event of patients reporting myo-
cardial infarction or congestive cardiac failure at
follow-up, confirmation was sought from the patient’s
primary care physician.Statistical methods
Descriptive variables are presented as means with
standard deviations (SD), or medians with interquar-
tile ranges (IQR), and compared with the t-test or
Mann Whitney test respectively. Estimations of preci-
sion are to be presented with 95% confidence inter-
vals. Categorical data and frequencies are expressed
as percentage and compared with chi-square or Fish-
er’s exact test where appropriate. Conventional levels
Table 1. Patient demographics and co-morbidities
TnI positive TnI negative P
Sample size 20 23
Median age, years (IQR) 76 (10) 76 (9) 0.84
Males, n (%) 18 (90) 22 (96) 0.46
Cardiac risk factors, n (%)
415Myocardial Injury and Outcome after AAA Repairof significance (a of 0.05) were applied throughout.
Logistic regression was performed to identify risk fac-
tors for postoperative outcomes. Statistical analysis
was undertaken using SPSS for windows version
11.0 (Chicago, Illinois, USA) and S Plus version 6
(Seattle, Washington, USA).History of angina 9 (45) 2 (9) 0.006
History of hypertension 14 (70) 12 (52) 0.95
History of diabetes mellitus 2 (10) 1 (5) 0.47
History of smoking 14 (70) 16 (70) 0.98
History of
hypercholesterolemia
12 (60) 7 (30) 0.05
Medical History
Angina CCS, (IQR) 0 (0e1) 0 (0e0) 0.03
NYHA score, (IQR) 1 (1e2) 1 (1e2) 0.72
Previous myocardial
infraction, (%)
10 (60) 3 (25) 0.03
Previous coronary
revascularization, (%)
5 (25) 2 (9) 0.43
Cardiac failure, (%) 1 (5) 0 (0) 0.91
Left ventricular function,
(IQR)
2 (1) 1 (1) 0.06
Renal impairment* (%) 1 (5) 1 (4) 0.91
GFR, mL/min (SD) 58 (20) 65 (27) 0.30
Cardiac medications, (%)
Beta-blocker 10 (45) 7 (30) 0.32
Calcium channel antagonist 6 (30) 6 (30) 0.97
ACE or AIIR inhibitor 10 (50) 5 (32) 0.24
Nitrate 3 (15) 4 (17) 0.83
Statin 10 (50) 8 (35) 0.31
Antiplatelet 14 (70) 10 (44) 0.08
Anticoagulant 1 (4) 1 (5) 0.92
IQR, Inter-quartile range; CCS, Canadian Classification Score;
NYHA, New York Heart Association; CABG, Coronary Artery
Bypass Grafting; GFR, Glomerular Filtration Rate; ACE, Angioten-
sin Converting Enzyme; AIIR, Angiotensin II Receptor.
* Renal impairment was defined as peak serum creatinine> 177
mmol/L (2.0 mg/dL) according to guidelines for risk stratification
in patients undergoing major vascular surgery and noncardiac
surgery.2Results
Of the 43 patients, 11 patients (27%) were referred for
noninvasive stress testing following cardiology con-
sultation, all of whom had a history of cardiac symp-
toms (exertional chest pain or dyspnea). Of these three
underwent coronary angiography and 8 non-invasive
stress testing. Three patients subsequently underwent
revascularization by percutaneous coronary interven-
tion. These were the only patients revascularized
within three to six months of AAA surgery. The
remaining 8 patients were treated medically, predom-
inantly through increaseing pre-existing anti-anginal
medication dosages. Seven patients had previous re-
vascularization greater than 6 months prior to referral
for AAA surgery.
Twenty patients (47%) had postoperative myocar-
dial injury. The majority of peak TnI measurements
occurred on postoperative days 1 (40%) and 3 (35%).
Patients who suffered myocardial injury were signifi-
cantly more likely to have a history of angina, hyper-
cholesterolemia, higher Canadian Classification
Angina scores, and suffered a previous myocardial
infarction at baseline (Table 1). The operative charac-
teristics of the two groups were similar with regards
to aneurysm size, aortic cross-clamp time and total
operative time, however patients who had myocardial
injury had significantly higher physiological risk
scores (Table 2). Median time to event was 138 days
(IQR 93) in the myocardial injury group compared
to 160 days (IQR 140) in the Tn negative group
(P¼ 0.39) Of the 20 patients who had myocardial
injury, 11 (55%) suffered a myocardial infarction in
hospital. All 11 had raised TnI levels and diagnostic
ECGs in the absence of chest pain. Two patients
died in hospital as a consequence.
Mean ( SD) follow-up was 571 291 days. One
patient refused follow-up. During the follow-up pe-
riod, 12 (28%) subjects experienced at least one end-
point event. Four (9%) patients died, 6 (14%)
suffered a myocardial infarction, and 2 (5%) devel-
oped congestive cardiac failure (Table 3). Of the 4
deaths, 2 were in patients with myocardial injury
(P¼ 0.83). Of the 6 myocardial infarctions, 5 were in
patients with myocardial injury (P¼ 0.05). Four of
these events were reinfarctions. Both of the patientswho developed cardiac failure had perioperative
myocardial injury (P¼ 0.12). Event free survival was
72% overall, 55% in patients who suffered myocardial
injury compared to 87% in those without elevations in
TnI (P¼ 0.02) (Table 3). Logistic regression analysis re-
vealed that myocardial injury was an independent
predictor of outcome with an odds ratio of 5.4 (95%
confidence interval 1.2e24, P¼ 0.03) (Table 4). Fur-
thermore, patients with myocardial injury, were sig-
nificantly more likely to be admitted to the intensive
care unit postoperatively (P¼ 0.05), although total
hospital stay was not significantly different between
the two groups (Table 2).
Renal injury, a consequence of hemodynamic
changes following application of the aortic cross-
clamp and ischemia-reperfusion injury following its
release, is also a common cause of morbidity and mor-
tality following elective AAA repair.20,21 Importantly,
the incidence of renal impairment and glomerularEur J Vasc Endovasc Surg Vol 35, April 2008
Table 2. Operative characteristics and postoperative outcomes
TnI positive TnI negative P
Median AAA diameter, cm (IQR) 6.7 (1.8) 6.5 (1.5) 0.25
Median ASA score (IQR) 3 (0) 3 (0) 0.59
Median POSSUM Physiology
Score, (IQR)
24 (9) 19 (8) 0.02
Median POSSUM Operative
Score, (IQR)
20 (3) 20 (4) 0.72
Supra-renal clamp, n (%) 3 (15) 2 (9) 0.52
Median blood loss, mL (IQR) 1250 (1025) 1450 (1178) 0.34
Median cross-clamp time, mins
(IQR)
55 (29) 59 (22) 0.35
Median operating time, mins
(IQR)
190 (42) 190 (87) 1.0
ICU admission*, n (%) 13 (65) 8 (35) 0.05
Postoperative stay, days (IQR) 12 (7) 9 (9) 0.13
AAA, Abdominal Aortic Aneurysm Repair, IQR, Inter-quartile
range; ASA, American Society of Anesthesiologists; POSSUM, phys-
iological operative severity score for the enumeration of mortality
and morbidity, ICU, Intensive Care Unit; SD, Standard Deviation.
* Patients were routinely monitored in the operating room recov-
ery for 24 hours postoperatively. Transfer to the ICU was based on
postoperative recovery.
Table 4. Logistic regression analysis of predictors of outcome in
patients undergoing elective open abdominal aortic aneurysm
repair
Univariable Predictors of Outcome
Variable OR 95% CI P
TnI elevation 5.4 1.2e24 0.03
Age, per year 1.0 0.91e1.1 0.71
Previous myocardial infarction 1.5 0.36e6.3 0.58
Angina 0.95 0.16e5.8 0.96
NYHA III/IV 2.3 0.64e8.4 0.20
Diabetes mellitus 6.0 0.49e73 0.16
Hypertension 1.9 0.46e7.5 0.37
Smoking 0.33 0.13e1.4 0.13
Hypercholesterolemia 1.1 0.29e4.4 0.83
ECG abnormalities* 1.2 0.33e1.2 0.11
Antiplatelet therapy 0.72 0.19e2.8 0.63
POSSUM risk score, per unit 1.1 0.96e1.2 0.18
Total operative time, per min 1.0 0.99e1.0 0.25
Total cross-clamp time, per min 0.98 0.92e1.0 0.49
Aneurysm size, per cm 0.73 0.38e1.4 0.36
OR, odds ratio; CI, confidence intervals; NYHA, New York Heart
Association; POSSUM, physiological operative severity score for
the enumeration of mortality and morbidity.
* ECGs were screened for AV block, uncontrolled SVT, pathologi-
cal Q waves, LVH, LBBB, and ST-T wave abnormalities.
416 Z. A. Ali et al.filtration rate were similar between the two groups
(Table 1). Furthermore, both the incidence of new
renal impairment and change from baseline glomeru-
lar filtration rate were not different between the myo-
cardial injury and Tn negative groups (Table 5),
excluding the potentially confounding effect that
myocardial injury was simply a marker of renal
impairment.Table 5. Incidence of postoperative renal impairment and GFR
change from baselineDiscussion
In this observational cohort study, we investigated the
prognostic implications of serum TnI elevations after
elective open AAA repair. We observed, first, that
patients with myocardial injury were higher risk pa-
tients and were significantly more likely to have risk
factors for cardiovascular disease. Second, over half
of patients with myocardial injury suffered a myocar-
dial infarction according to ACC/AHA guidelines.
Finally, at a mean follow-up of 1.5 years, survival
free of cardiac failure or myocardial infarction wasTable 3. Major adverse outcomes after open AAA repair after
discharge
TnI positive TnI negative P value
Sample size 20 23
Myocardial infarction, n (%) 5 (25) 1 (4) 0.05
Cardiac failure, n (%) 2 (10) 0 0.12
Death, n (%) 2 (10) 2 (9) 0.83
*Composite, n (%) 9 (45) 3 (13) 0.02
* Composite defined as death, congestive cardiac failure, or myo-
cardial infarction; only one event for each patient was counted.
Eur J Vasc Endovasc Surg Vol 35, April 2008significantly lower in patients with perioperative
myocardial injury. Logistic regression analysis re-
vealed that myocardial injury was an independent
predictor of outcome.
Following elective AAA repair the commonest
cause for perioperative death is cardiac-related.22,23
Significant coronary artery disease is present in half
to two-thirds of these patients.24,25 Cross-clamping
of the abdominal aorta leads to a sudden increase in
afterload and subsequent subendocardial ische-
mia3,26,27 which rarely presents with chest pain.4 The
emergence of highly sensitive markers of myocardial
damage such as TnI and T have revealed that myo-
cardial necrosis is common. In magnetic resonance






Day 1 e New renal
impairment, n (%)
3 (15) 9 (39) 0.08
Day 1 e GFR, mL/min (SEM) 8 (3) 9 (7) 0.84
Day 3 e New renal
impairment, n (%)
0 (0) 4 (17) 0.05
Day 3 e GFR, mL/min (SEM) 4 (4) 5 (8) 0.63
Day 7 e New renal
impairment, n (%)
0 (0) 0 (0) N/A
Day 7 e GFR, mL/min (SEM) 1 (3) 2 (5) 0.30
GFR, Glomerular Filtration Rate.
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patients with a ruptured AAA, the incidence of TnI
elevation has been reported between 46-58%.12,13 Re-
cently, it was shown that elevations in this cardiac
marker, in the presence or absence of overt cardiac
dysfunction, were associated with perioperative
death.13 However, in addition to cardiovascular co-
morbidity, these patients suffer ischemic stress as
a result of massive hemorrhage and transfusion. To
determine the prognostic implications of myocardial
injury after elective open AAA repair we performed
a prospective observational cohort study and found,
at a mean follow-up of 1.5 years, survival free of car-
diac failure or myocardial infarction was 32% lower in
patients with TnI elevations. These findings support
previous studies which show myocardial injury is
prognostic in both vascular surgery patients5,7e11
and non-cardiac surgery patients.29,30
Patients with myocardial injury had significantly
higher physiological risk scores and more cardiovas-
cular risk factors. These findings highlight the impor-
tance of using preoperative cardiac risk evaluation
and longer term cardiology follow-up in these pa-
tients. In light of a recent large randomized controlled
trial which determined that routine coronary artery
revascularization before elective AAA surgery failed
to significantly alter long-term outcome,31 the need
to identify patients at risk of cardiac morbidity and
mortality remains paramount. Markers of myocardial
injury, such as TnI, may be able to identify such pa-
tients. In our study, of the 6 patients with follow-up
myocardial infarctions, 5 were in patients with myo-
cardial injury, four of which were reinfarctions. In
the nine patients who had perioperative myocardial
injury and a subsequent endpoint event at follow-
up, the median TnI level was 4.78 (IQR 0.61e23.64).
These patients may benefit from optimization of car-
dioprotective medical therapies associated with
survival benefits such as aspirin, beta-blockers, angio-
tensin converting enzyme inhibitors and statins.32
It would appear initially that the 47% incidence of
Tn elevation compared to that reported in the litera-
ture is high. Critically, most previous studies investi-
gating the prognostic implications of Tn elevation
after myocardial injury have been for major vascular
surgery, which includes infrainguinal bypass surgery,
as opposed to specifically AAA repair. In these stud-
ies the incidence is reported to be between
10e23%.5,8e10,31,33 However, cross-clamping of the ab-
dominal aorta for AAA repair leads to a markedly dif-
ferent physiological and hemodynamic response to
cross clamping the iliac artery for infrainguinal revas-
cularisation procedures.34 In studies looking directly
at AAA repair Haggart and collegues foundmyocardial damage, as assessed by cardiac troponin
I elevation, complicated 58% of emergency and 30%
of elective AAA repairs. Abraham and collegues15 re-
ported a 25% incidence of troponin elevation on a sin-
gle recording 24 hours following AAA repair.
Recently, Schouten and collegues showed Tn eleva-
tions in 47% of patients with >3 cardiovascular risk
factors undergoing conventional open AAA repair.16
In the face of other trials describing myocardial ische-
mia seen as significant ST segment depression on ECG
in 30-40% of patients having elective AAA repair,14,35
the authors believe that in the face of increasingly sen-
sitive Tn assays, that the incidence of myocardial
injury in these high risk patients is accurate.
In keeping with previous reports showing under-
utilization of cardiac medical therapy among patients
undergoing AAA repair,36 in our study population,
more than half of patients undergoing surgery were
not treated with these drugs preoperatively. The au-
thors are unable to confirm how the present findings
on postoperative outcome would be affected by
increased utilization of cardiac medications. However,
in keeping with previous reports it is likely that opti-
mization of medical therapy would have reduced
perioperative events. Nevertheless, the authors be-
lieve that the findings of the present study are valu-
able as they highlight that postoperative outcome is
worse in those patients with perioperative troponin
elevation, irrespective of there medical and operative
risk. When patients who had myocardial injury and
subsequently suffered an event were compared to pa-
tients with myocardial injury who remained free from
subsequent events, we found no significant differ-
ences in baseline or operative characteristics (data
not shown). These findings indicate that events in pa-
tients with myocardial injury were not simply a reflec-
tion of increased preoperative cardiovascular/
operative risk, but were related to postoperative myo-
cardial injury.
Determining the prognostic implications of raised
TnI levels after elective open AAA repair has become
particularly important in the face of new data show-
ing that endovascular therapy attenuates myocardial
injury. Abraham and colleagues reported an 18% ab-
solute risk reduction in the incidence of raised tropo-
nin, despite a 19% higher rate of preoperative
myocardial infarction. Similarly, Schouten and co-
workers showed a benefit favoring endovascular
repair in reducing cardiovascular outcomes.16,37 De-
spite this finding, the incidence of long-term cardiac
mortality was similar in both groups. These findings
suggest the possibility that the surgical stress of aortic
clamping and subsequent hemodynamic instability in
elective open surgery simply unveil cardiovascularEur J Vasc Endovasc Surg Vol 35, April 2008
418 Z. A. Ali et al.disease in the perioperative period which may remain
masked in patients who undergo endovascular repair.
In conclusion, we have demonstrated that elevation
in TnI after elective open AAA repair predicts out-
come 1.5 years after surgery. Techniques to reduce
myocardial injury may be able to improve morbidity
and mortality after AAA repair. Furthermore, patients
with TnI elevations were significantly higher risk and
had a higher incidence of cardiovascular risk factors.
Routine TnI measurement should be considered in
all patients at high cardiovascular risk to allow appro-
priate follow-up and optimization of medical therapy.References
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